Endoscopic supraglottic laryngectomy: a proposal for a classification by the working committee on nomenclature, European Laryngological Society.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 19130072)

Published in Eur Arch Otorhinolaryngol on January 08, 2009

Authors

Marc Remacle1, Anastasios Hantzakos, Hans Eckel, Anne-Sophie Evrard, Patrick J Bradley, Dominique Chevalier, Vojko Djukic, Marco de Vincentiis, Gerhard Friedrich, Jan Olofsson, Giorgio Peretti, Miquel Quer, Jochen Werner

Author Affiliations

1: Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital of Louvain at Mont-Godinne, 5530, Yvoir, Belgium. marc.remacle@uclouvain.be

Articles citing this

Open partial horizontal laryngectomies: a proposal for classification by the working committee on nomenclature of the European Laryngological Society. Eur Arch Otorhinolaryngol (2014) 1.42

Transoral robotic surgery for the management of head and neck tumors: learning curve. Eur Arch Otorhinolaryngol (2011) 1.07

Supracricoid laryngectomy with cricohyoidoepiglottopexy (CHEP) in the management of laryngeal carcinoma: oncologic results. A 35-year experience. Eur Arch Otorhinolaryngol (2012) 0.86

Transoral CO2 laser microsurgery for Tis-T3 supraglottic squamous cell carcinomas. Eur Arch Otorhinolaryngol (2010) 0.84

Combining a new CO2 laser wave guide with transoral robotic surgery: a feasibility study on four patients with malignant tumors. Eur Arch Otorhinolaryngol (2011) 0.84

Supracricoid laryngectomies: oncological and functional results for 152 patients. Acta Otorhinolaryngol Ital (2014) 0.84

Transoral CO2 laser management for selected supraglottic tumors and neck dissection. Eur Arch Otorhinolaryngol (2011) 0.79

Functional organ preservation in laryngeal and hypopharyngeal cancer. GMS Curr Top Otorhinolaryngol Head Neck Surg (2012) 0.75

Functional outcomes of supraglottic squamous cell carcinoma treated by transoral laser microsurgery compared with horizontal supraglottic laryngectomy in patients younger and older than 65 years. Acta Otorhinolaryngol Ital (2016) 0.75

The learning curve in the use of trans-oral laser microsurgery for cancer treatment. Eur Arch Otorhinolaryngol (2013) 0.75

Complications in CO2 Laser Transoral Microsurgery for Larynx Carcinomas. Int Arch Otorhinolaryngol (2015) 0.75

Reply to the comment to the article "Open partial horizontal laryngectomies: a proposal for classification by the working committee on nomenclature of the European Laryngological Society". Eur Arch Otorhinolaryngol (2014) 0.75

The role of ultrasonic instruments in pharyngolaryngeal endoscopic surgery. Eur Arch Otorhinolaryngol (2015) 0.75

Articles cited by this

Endoscopic cordectomy. A proposal for a classification by the Working Committee, European Laryngological Society. Eur Arch Otorhinolaryngol (2000) 1.76

Results of curative laser microsurgery of laryngeal carcinomas. Am J Otolaryngol (1993) 1.51

Conservation surgery for carcinoma of the supraglottis. J Laryngol Otol (1970) 1.38

Experience in endoscopic laser surgery of malignant tumours of the upper aero-digestive tract. Adv Otorhinolaryngol (1988) 1.13

Transoral laser surgery of supraglottic cancer: follow-up of 141 patients. Arch Otolaryngol Head Neck Surg (1998) 1.03

Conservation surgery for epidermoid carcinoma of the supraglottic larynx. Laryngoscope (1975) 0.98

Functional outcomes of transoral laser surgery of supraglottic carcinoma compared with a transcervical approach. Head Neck (2004) 0.96

Transoral laryngeal surgery using the CO2 laser: laboratory experiments and clinical experience. Laryngoscope (1978) 0.95

Carbon dioxide laser microsurgery for early supraglottic carcinoma. Ann Otol Rhinol Laryngol (1998) 0.95

Intralaryngeal barriers to the spread of cancer. Acta Otolaryngol (1987) 0.95

Endoscopic treatment of supraglottic and hypopharynx cancer. Laryngoscope (1994) 0.91

Supraglottic laryngectomy with or without postoperative radiotherapy in supraglottic carcinomas. Ann Otol Rhinol Laryngol (1995) 0.90

Transoral carbon dioxide laser resection of supraglottic carcinoma. Ann Otol Rhinol Laryngol (1999) 0.90

The periepiglottic space: topographic relations and histological organisation. J Anat (1996) 0.89

Comparison of functional outcomes after endoscopic versus open-neck supraglottic laryngectomies. Ann Otol Rhinol Laryngol (2006) 0.87

CO2 laser treatment of supraglottic cancer. Head Neck (2004) 0.86

Conservative surgery of cancer of the larynx. Trans Am Acad Ophthalmol Otolaryngol (1947) 0.85

Location of the preepiglottic space and its relationship to the paraglottic space. Ann Otol Rhinol Laryngol (1993) 0.84

Supraglottic laryngectomy: 30 years of experience. Ann Otol Rhinol Laryngol (1983) 0.84

Glottic-supraglottic barrier: fact or fantasy? Ann Otol Rhinol Laryngol (1997) 0.83

Laser epiglottectomy: endoscopic technique and indications. Otolaryngol Head Neck Surg (1990) 0.83

Swallowing function after endoscopic resection of supraglottic carcinoma with the carbon dioxide laser. Eur Arch Otorhinolaryngol (2001) 0.83

Laser surgery for the treatment of larynx carcinomas: indications, techniques, and preliminary results. Ann Otol Rhinol Laryngol (1992) 0.82

Supraglottic laryngectomy: functional and oncologic results. Ann Otol Rhinol Laryngol (1996) 0.81

Endoscopic laser management of supraglottic cancer. Am J Otolaryngol (1995) 0.81

Endoscopic laser resection of supraglottic carcinoma. Otolaryngol Head Neck Surg (1997) 0.81

Endoscopic resections of glottic and supraglottic carcinomas with the CO2 laser. Eur Arch Otorhinolaryngol (1995) 0.79

Endoscopic supraglottic laryngectomy with postoperative irradiation. Ann Otol Rhinol Laryngol (2004) 0.78

Endoscopic CO2 laser excisional biopsy of early supraglottic cancer. Laryngoscope (1991) 0.77

Potential role of transoral laser surgery for larynx carcinoma. Lasers Surg Med (1998) 0.76

[The CO2 laser in laryngeal microsurgery]. Acta Otorhinolaryngol Ital (1984) 0.75

Borders and topographic relationships of the paraglottic space. Eur Arch Otorhinolaryngol (1997) 0.75

Articles by these authors

Paragangliomas of the head and neck. Oral Oncol (2004) 2.47

Proposal for revision of the European Laryngological Society classification of endoscopic cordectomies. Eur Arch Otorhinolaryngol (2007) 2.30

Vascularized tissue to reduce fistula following salvage total laryngectomy: a systematic review. Laryngoscope (2014) 2.21

Second, third, and fourth head and neck tumors. A progressive decrease in survival. Head Neck (2012) 1.97

Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study. J Clin Oncol (2013) 1.74

The role of type of tobacco and type of alcoholic beverage in oral carcinogenesis. Int J Cancer (2004) 1.63

Continuous laryngoscopy exercise test: a method for visualizing laryngeal dysfunction during exercise. Laryngoscope (2006) 1.62

Laryngeal electromyography: a proposal for guidelines of the European Laryngological Society. Eur Arch Otorhinolaryngol (2012) 1.55

Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa. J Infect Dis (2002) 1.48

Indications and results of anterior mediastinal tracheostomy for malignancies. Ann Thorac Surg (2010) 1.44

Preoperative clinical predictors of difficult laryngeal exposure for microlaryngoscopy: the Laryngoscore. Laryngoscope (2014) 1.42

Airway management and anesthesia in neonates, infants and children during endolaryngotracheal surgery. Paediatr Anaesth (2007) 1.40

EMLA(®) cream as local anesthetic for radiofrequency turbinate tissue reduction. Eur Arch Otorhinolaryngol (2014) 1.40

Update on hemangiomas and vascular malformations of the head and neck. Eur Arch Otorhinolaryngol (2008) 1.39

[A four-year-old boy with swollen cheek after a fall]. Tidsskr Nor Laegeforen (2005) 1.39

Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck (2010) 1.34

Management of sarcomas of the head and neck in adults. Oral Oncol (2003) 1.31

Functional endothelin receptors are present on nuclei in cardiac ventricular myocytes. J Biol Chem (2003) 1.30

Risk of hematological malignancies among Chernobyl liquidators. Radiat Res (2008) 1.28

Schwannoma of the sinonasal tract: a clinicopathologic and immunohistochemical study of 5 cases. Arch Pathol Lab Med (2003) 1.28

Neck disease and distant metastases. Oral Oncol (2003) 1.27

Narrow band imaging and high definition television in the assessment of laryngeal cancer: a prospective study on 279 patients. Eur Arch Otorhinolaryngol (2009) 1.27

CO2 laser cordectomy for early-stage glottic carcinoma: a long-term follow-up of 156 cases. Laryngoscope (2002) 1.26

Comorbidity in head and neck cancer: a critical appraisal and recommendations for practice. Oral Oncol (2010) 1.26

Human papillomavirus infections in laryngeal cancer. Head Neck (2011) 1.22

Lymphadenopathy caused by Mycobacterium colombiense. J Clin Microbiol (2008) 1.20

Head and neck intramuscular haemangioma: report of two cases with unusual localization. Eur Arch Otorhinolaryngol (2003) 1.19

Risks of malignancy in inverted papilloma of the nose and paranasal sinuses. Curr Opin Otolaryngol Head Neck Surg (2007) 1.17

The oncologic radicality of supracricoid partial laryngectomy with cricohyoidopexy in the treatment of advanced N0-N1 laryngeal squamous cell carcinoma. Laryngoscope (2012) 1.14

Endoscopic management of laryngo-tracheobronchial amyloidosis: a series of 32 patients. Eur Arch Otorhinolaryngol (2003) 1.12

Management of malignant sublingual salivary gland tumors. Oral Oncol (2004) 1.11

Second primary tumors in head and neck cancer patients. Acta Otolaryngol (2002) 1.08

Rosai-Dorfman disease in the larynx. Ear Nose Throat J (2013) 1.07

Complications of free flap transfers for head and neck reconstruction following cancer resection. Oral Oncol (2004) 1.06

Proposal for a rational classification of neck dissections. Head Neck (2010) 1.04

Hypothyroidism in patients treated with total laryngectomy. A multivariate study. Eur Arch Otorhinolaryngol (2002) 1.02

Anaesthesia in endoscopic sinus surgery. Eur Arch Otorhinolaryngol (2003) 1.02

Interaction between head and neck squamous cell carcinoma cells and fibroblasts in the biosynthesis of PGE2. J Lipid Res (2012) 1.01

Management dilemmas in the treatment and follow-up of advanced juvenile nasopharyngeal angiofibroma. ORL J Otorhinolaryngol Relat Spec (2006) 1.00

Diagnosis and classification of salivary neoplasms: pathologic challenges and relevance to clinical outcomes. Acta Otolaryngol (2002) 1.00

Variability in nerve patterns of the adductor muscle group supplied by the recurrent laryngeal nerve. Laryngoscope (2005) 0.99

Patients' perspectives on the short- and long-term outcomes following surgery for benign parotid neoplasms. J Laryngol Otol (2003) 0.99

Role of narrow-band imaging and high-definition television in the surveillance of head and neck squamous cell cancer after chemo- and/or radiotherapy. Eur Arch Otorhinolaryngol (2010) 0.99

Supracricoid partial laryngectomy in the treatment of laryngeal cancer: univariate and multivariate analysis of prognostic factors. Arch Otolaryngol Head Neck Surg (2005) 0.99

Middle ear glandular neoplasms: adenoma, carcinoma or adenoma with neuroendocrine differentiation: a case series. Cases J (2009) 0.99

Exercise-induced laryngeal obstruction: natural history and effect of surgical treatment. Eur Arch Otorhinolaryngol (2011) 0.98

Salvage conservation laryngeal surgery after irradiation failure for early laryngeal cancer. Laryngoscope (2006) 0.98

Galectin 7 (p53-induced gene 1): a new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer. Ann Surg Oncol (2006) 0.97

Evolution of the management of laryngeal cancer. Oral Oncol (2006) 0.96

Inclusion of extracapsular spread in the pTNM classification system: a proposal for patients with head and neck carcinoma. JAMA Otolaryngol Head Neck Surg (2013) 0.96

Analysis of forces applied during microlaryngoscopy: a descriptive study. Eur Arch Otorhinolaryngol (2008) 0.96

Is the external laryngeal nerve an exclusively motor nerve? The cricothyroid connection branch. Laryngoscope (2003) 0.96

Management of the N0 neck--reference or preference. Oral Oncol (2005) 0.95

Narrow band imaging in endoscopic evaluation of the larynx. Curr Opin Otolaryngol Head Neck Surg (2012) 0.95

Multicentric prospective study on the prevalence of sublevel IIb metastases in head and neck cancer. Arch Otolaryngol Head Neck Surg (2007) 0.94

The effect of waiting time on local control and survival in head and neck carcinoma patients treated with radiotherapy. Radiother Oncol (2003) 0.94

Detection of human papillomavirus and adenovirus in benign and malignant lesions of the larynx. Otolaryngol Head Neck Surg (2009) 0.94

Questionable necessity to remove the submandibular gland in neck dissection. Head Neck (2010) 0.94

Influence of the persistence of tobacco and alcohol use in the appearance of second neoplasm in patients with a head and neck cancer. A case-control study. Cancer Causes Control (2008) 0.94

Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial). Eur Arch Otorhinolaryngol (2008) 0.94

Head and neck specific Health Related Quality of Life scores predict subsequent survival in successfully treated head and neck cancer patients: a prospective cohort study. Oral Oncol (2011) 0.93

Exercise induced dyspnea in the young. Larynx as the bottleneck of the airways. Respir Med (2009) 0.93

Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer. Int J Cancer (2008) 0.93

Voice results in patients with T1a glottic cancer treated by radiotherapy or endoscopic measures. Eur Arch Otorhinolaryngol (2002) 0.92

Sudden sensorineural hearing loss: a vascular cause? Analysis of prothrombotic risk factors in head and neck. Int J Audiol (2012) 0.92

Prediction of survival by pretreatment health-related quality-of-life scores in a prospective cohort of patients with head and neck squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg (2013) 0.92

Swallowing ability and chronic aspiration after supracricoid partial laryngectomy. Otolaryngol Head Neck Surg (2010) 0.92

Audiovisual assessment of exercise-induced laryngeal obstruction: reliability and validity of observations. Eur Arch Otorhinolaryngol (2009) 0.91

Foramen of Huschke: case report and experimental procedure for diagnosis of spontaneous salivary fistula. J Oral Maxillofac Surg (2009) 0.91

Short German guidelines: basal cell carcinoma. J Dtsch Dermatol Ges (2008) 0.91

Nasalance changes after functional endoscopic sinus surgery. J Voice (2002) 0.90

Personality and choice of coping predict quality of life in head and neck cancer patients during follow-up. Acta Oncol (2008) 0.90

Metachronous second primary tumours in the aerodigestive tract in patients with early stage head and neck squamous cell carcinomas. Eur Arch Otorhinolaryngol (2005) 0.90

New molecular diagnostic methods in head and neck cancer. Head Neck (2005) 0.90

Comparison of the Radiation Therapy Oncology Group recursive partitioning classification and Union Internationale Contre le Cancer TNM classification for patients with head and neck carcinoma. Head Neck (2005) 0.90

Novel approach to complex pulmonary arteriovenous malformation embolization using detachable coils and Amplatzer vascular plugs. Eur J Radiol (2012) 0.90

Quality of life in head and neck cancer. Acta Otolaryngol (2003) 0.90

Phonosurgery after endoscopic cordectomies. II. Delayed medialization techniques for major glottic incompetence after total and extended resections. Eur Arch Otorhinolaryngol (2007) 0.90

Diagnostic accuracy of magnetic resonance imaging in the assessment of mandibular involvement in oral-oropharyngeal squamous cell carcinoma: a prospective study. Arch Otolaryngol Head Neck Surg (2004) 0.90

Pleomorphic salivary adenoma of the parotid gland: which operation to perform? Curr Opin Otolaryngol Head Neck Surg (2004) 0.90

The distribution of lymph node metastases in supraglottic squamous cell carcinoma: therapeutic implications. Head Neck (2002) 0.90

Management of Thyroid nodules in adult patients. Head Neck Oncol (2010) 0.89

Prostaglandin E(2) pathway in head and neck squamous cell carcinoma. Head Neck (2008) 0.89

Stimulated monocyte IL-6 secretion predicts survival of patients with head and neck squamous cell carcinoma. BMC Cancer (2008) 0.89

Surgery of adult bilateral vocal fold paralysis in adduction: history and trends. Eur Arch Otorhinolaryngol (2008) 0.89

Surgical treatment of exercise-induced laryngeal dysfunction. Eur Arch Otorhinolaryngol (2007) 0.89

Role of genetic and acquired prothrombotic risk factors in genesis of sudden sensorineural hearing loss. Audiol Neurootol (2010) 0.88

Galectin-3 upregulation during tumor progression in head and neck cancer. Laryngoscope (2008) 0.87

Mood, anxiety and sense of humor in head and neck cancer patients in relation to disease stage, prognosis and quality of life. Acta Otolaryngol (2005) 0.87

Risk of thyroid cancer among chernobyl liquidators. Radiat Res (2012) 0.87

Recent changes in the treatment of patients with advanced laryngeal cancer. Head Neck (2008) 0.86

Presence of activated T lymphocytes in peripheral blood of head and neck squamous cell carcinoma patients predicts impaired prognosis. Acta Otolaryngol (2006) 0.86